Head to head for first-timers
CoreAge Rx vs Next Vial
CoreAge Rx and Next Vial both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #31 for first-timers · Grade C
Mama-Match
Best for: Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
Visit CoreAge RxNext Vial
Rank #189 for first-timers · Grade C
Mama-Match
Best for: A mom who wants a real monthly price, with a large discount available if a year up front is possible.
Visit Next VialThe verdict for a first step
CoreAge Rx edges out Next Vial on the Mama-Match Score, 73 to 53 (C vs C). Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
Next Vial is still a genuine option — the plan selector is one of the cleanest I have seen: $199 a month, or $169, $149 and $99 over three, six and twelve months, and I checked every division — they are exact. Semaglutide and tirzepatide cost the same. And then you look at the top of that same page: "Doctor-Led Weight Loss Plans as Low as $249.97/Month". That figure is nowhere in the selector, and it is two and a half times what its cheapest plan costs. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | Next Vial |
|---|---|---|
| Mama-Match Score | 73/100 · C | 53/100 · C |
| Overall rank | #31 | #189 |
| Semaglutide | $99/mo | $199/mo paying month to month |
| Tirzepatide | $149/mo | $199/mo paying month to month |
| Coverage | Therapy-specific state restrictions; confirm eligibility | Not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #31 · Grade C
What we like
- Published prices for both molecules, with the same advertised amount at each dose
- The offer includes medication, consultation and shipping, without an advertised membership fee
- The legal footer identifies the platform and the entities responsible for clinical care
The caveats
- The main site and a separate offer page show different prices
- The FAQ and policy differ on automatic rebilling and denial refunds
- State restrictions; orders become final when sent to pharmacy, with a 30-day refund cutoff
Mama-Match
Next Vial
Rank #189 · Grade C
What we like
- A genuine month-to-month option at $199, not just prepaid plans
- Every total divides exactly: $507, $894, $1,188, $477, $834 and $948
- Semaglutide and tirzepatide cost the same, so switching molecules costs nothing
The caveats
- ⛔ The headline on that same page says "as low as $249.97/Month", above every plan it offers
- The $99 rate requires $1,188 up front
- The microdose route starts at three months; there is no single month
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Next Vial with the other providers we review for women.
Or browse the full comparison hub.